Login / Signup

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.

Paolo Della BellaFrancesca BarattoPasquale VergaraPatrizia BertocchiMatteo SantamariaPasquale NotarstefanoLeonardo CalòDaniela OrsidaLuca TomasiMarcello PiacentiStefano SangiorgioFrancesco PentimalliEtienne PruvotJoão De SousaFrédéric SacherMassimo TrittoLuca RebellatoThomas DenekeSalvo Andrea RomanoMartina NestiAlessio GargaroDaniele GiacopelliGiovanni PerettoAndrea Radinovic
Published in: Circulation (2022)
gov; Unique identifier: NCT01547208.
Keyphrases
  • phase iii
  • double blind
  • phase ii
  • placebo controlled
  • clinical trial
  • open label
  • study protocol
  • cross sectional
  • catheter ablation